Curriculum
As a PGY-2 investigational drugs and research resident, you devote much of your time to comprehensive training as a member of the interdisciplinary team. A breadth of learning experiences has been designed to increase and refine your clinical competency, provide evidence-based pharmacotherapeutic care plans, and develop your confidence as an independent practitioner.
You will provide patient-specific investigational drug care services and assist clinical trial teams by managing investigational drug dispensing. Responsibilities include reviewing both cancer and non-cancer clinical trial protocols, directly handling investigational drugs, and working to ensure their safe administration. After coaching, instruction, and modeling by a preceptor, you are assessed and constructively critiqued on how to further refine the delivery of evidence-based recommendations.
You will provide investigational drug information to physicians, nurses, pharmacists, and other members of study teams. You will also interact with drug sponsors and other allied health professionals. Feedback is provided to enhance your drug-information retrieval skills using a variety of resources and modalities.
Required learning experiences
The PGY-2 Pharmacy Residency in Investigational Drugs and Research at Mayo Clinic — Rochester is designed to provide a diverse experience for future investigational drugs services clinicians. Required learning experiences include:
| Area | Length |
|---|---|
| Orientation | 4 weeks |
| Introduction to Investigational Drug EMR Builds | 2 weeks |
| Institutional Review Board (IRB) | 2 weeks |
| Investigational Drug Services - Non-cancer inpatient I | 6 weeks |
| Investigational Drug Services - Cancer center I | 4 weeks |
| Cancer Care Infusion Center | 4 weeks |
| Investigational Drug Services - Non-cancer outpatient I | 4 weeks |
| Investigational Drug Services - Cancer center II | 4 weeks |
| Investigational Drug Services - Non-cancer inpatient II | 6 weeks |
| Pharmacy leadership and administration | Longitudinal, 12 months |
| Research | Longitudinal, 12 months |
| Staffing | Longitudinal, 12 months |
| Teaching and learning | Longitudinal, 12 months |
| Quality improvement | Longitudinal, 12 months |
Elective learning
A host of elective learning experiences are available to allow the resident to tailor the program to their interests in both cancer and non-cancer research.
- Pediatric oncology (4 weeks)
- Investigational Drug Services- Non-cancer outpatient II (4-6 weeks)
- Investigational Drug Services- Cancer center III (4 weeks)
- Investigational Drug Services- Non-cancer inpatient III (4-6 weeks)
- Production Pharmacy Lab (2 weeks)
- Clinical study team management (2 weeks)
Staffing commitment
The PGY-2 investigational drugs and Research resident will provide approximately 24 hours of staffing every three weeks. Staffing may also include a combination of weekend and evening coverage as part of the on-call program.